The pharmaceutical company plans to cut $2 billion in annual expenses by the end of 2027 through “operational efficiencies across multiple areas of the business,” its CFO told analysts on a conference ...

Turning innovation into patents? It can be an uphill battle. Check out these five effective strategies to improve your odds ...

Unfortunately, failing to implement the necessary IP protections can leave a company vulnerable to copycat competitors that can reduce its valuation and weaken its brand.

ROBERT F. KENNEDY JR. expressed openness to adopting a key progressive proposal for lowering drug prices during a closed-door ...

I liked reading the always-excellent Rob Greenspoon's post about five (almost) instant fixes to the patent system. The next U ...

Of the 118 biologics losing exclusivity over the next decade, only 10% have biosimilars in development, meaning a vast ...